CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study
DOI 10.1055/a-2694-8248
Bibliografische Angaben
Nachweis in CareLit
Autor:innenAnurag Lila, Anima Sharma, Rohit Barnabas, Manjiri Karlekar, Saba Samad Memon, Vijaya Sarathi, Sameer Rege, Priyanka Verma, Gaurav Malhotra, Vikram Lele, Tushar Bandgar
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe05/2025
Jahrgang / SeitenJg. 64 · S. 301-307
Kernaussage aus der Literatur
Abstract-Vorschau
AbstractThe data on the use of 68Ga-NODAGA-exendin-4 PET/CT in localizing multiple endocrine neoplasia type 1 (MEN1)-related insulinomas is evolving; however, surgical outcomes data are not available. We describe our cohort of patients with MEN1-related endogenous hyperinsulinemic hypoglycemia (EHH), where 68Ga-NODAGA-exendin-4 PET/CT was used to guide conservative surgery. A retrospective record review of MEN1-rela…
Zitieren
Zitierempfehlung
Anurag Lila, Anima Sharma, Rohit Barnabas, Manjiri Karlekar, Saba Samad Memon, Vijaya Sarathi, Sameer Rege, Priyanka Verma, Gaurav Malhotra, Vikram Lele, Tushar Bandgar (2025) Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study. Nuklearmedizin - NuclearMedicine, 64 (05), 301-307. https://doi.org/10.1055/a-2694-8248
Mit CareLit weiterarbeiten